These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21170090)

  • 1. Cytotoxic T-lymphocyte antigen 4 haplotype correlates with relapse and survival after allogeneic hematopoietic SCT.
    Murase M; Nishida T; Onizuka M; Inamoto Y; Sugimoto K; Imahashi N; Murata M; Miyamura K; Kodera Y; Inoko H; Naoe T
    Bone Marrow Transplant; 2011 Nov; 46(11):1444-9. PubMed ID: 21170090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor.
    Qin XY; Wang Y; Li GX; Qin YZ; Wang FR; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    J Transl Med; 2016 Apr; 14():100. PubMed ID: 27118383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cytotoxic T-lymphocyte antigen-4 (CTLA-4) single nucleotide polymorphism in donors with clinical outcome after allogeneic hematopoietic stem cell transplantation: a meta-analysis.
    Wang Z; Zhang Y; Du Y; Song F; Gao S
    Hematology; 2021 Dec; 26(1):144-152. PubMed ID: 33491603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
    Bosch-Vizcaya A; Pérez-García A; Brunet S; Solano C; Buño I; Guillem V; Martínez-Laperche C; Sanz G; Barrenetxea C; Martínez C; Tuset E; Lloveras N; Coll R; Guardia R; González Y; Roncero JM; Bustins A; Gardella S; Fernández C; Buch J; Gallardo D;
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):100-5. PubMed ID: 21703972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.
    Pérez-García A; De la Cámara R; Román-Gómez J; Jiménez-Velasco A; Encuentra M; Nieto JB; de la Rubia J; Urbano-Ispizúa A; Brunet S; Iriondo A; González M; Serrano D; Espigado I; Solano C; Ribera JM; Pujal JM; Hoyos M; Gallardo D;
    Blood; 2007 Jul; 110(1):461-7. PubMed ID: 17384200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
    Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
    Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.
    Hammrich J; Wittig S; Ernst T; Gruhn B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):587-592. PubMed ID: 29335768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
    Karabon L; Markiewicz M; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
    Immunogenetics; 2015 Jun; 67(5-6):295-304. PubMed ID: 25940108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood.
    Hammrich J; Wittig S; Ernst T; Gruhn B
    Eur J Haematol; 2019 Mar; 102(3):251-255. PubMed ID: 30465728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
    Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
    Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in a chinese population.
    Xiao H; Cao W; Lai X; Luo Y; Shi J; Tan Y; He J; Xie W; Meng X; Zheng W; Zheng G; Han X; Jin L; Zhang L; Wang Y; Yu X; Cai Z; Lin M; Ye X; Huang H
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):542-9. PubMed ID: 20457266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.
    Xiao H; Luo Y; Lai X; Fu S; Shi J; Tan Y; He J; Xie W; Zheng W; Wang LM; Zhang L; Liu L; Ye X; Yu X; Cai Z; Lin M; Huang H
    Haematologica; 2012 Dec; 97(12):1804-12. PubMed ID: 22733023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
    Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 polymorphism and clinical outcome post allogeneic hematopoietic stem cell transplantation.
    Mossallam GI; Samra MA
    Hum Immunol; 2013 Dec; 74(12):1643-8. PubMed ID: 23973330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A retrospective comparative study of haplotype hematopoietic stem cell transplantation and human leukocyte antigen-matched sibling donor hematopoietic stem cell transplantation in the treatment of acute B-lymphocyte leukemia].
    Wang ZD; Sun YQ; Yan CH; Wang FR; Mo XD; Lyu M; Zhao XS; Han W; Chen H; Chen YY; Wang Y; Xu LP; Wang YZ; Liu YR; Cheng YF; Zhang XH; Liu KY; Huang XJ; Chang YJ
    Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):221-228. PubMed ID: 35405780
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.
    Jagasia M; Clark WB; Brown-Gentry KD; Crawford DC; Fan KH; Chen H; Kassim A; Greer JP; Engelhardt BG; Savani BN
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1069-75. PubMed ID: 22178694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.
    Sengsayadeth S; Wang T; Lee SJ; Haagenson MD; Spellman S; Fernandez Viña MA; Muller CR; Verneris MR; Savani BN; Jagasia M
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):900-3. PubMed ID: 24631737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.
    Piccioli P; Balbi G; Serra M; Morabito A; Lamparelli T; Gobbi M; Laurent S; Dozin B; Bruzzi P; Ferraris AM; Bacigalupo A; Notaro R; Pistillo MP
    Ann Hematol; 2010 Jun; 89(6):613-8. PubMed ID: 20020126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
    Wetzel L; Wittig S; Gruhn B
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.